185 related articles for article (PubMed ID: 31085459)
1. Juglone eliminates MDSCs accumulation and enhances antitumor immunity.
Wang H; Zou C; Zhao W; Yu Y; Cui Y; Zhang H; E F; Qiu Z; Zou C; Gao X
Int Immunopharmacol; 2019 Aug; 73():118-127. PubMed ID: 31085459
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice.
Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M
Int Immunopharmacol; 2017 Jun; 47():173-181. PubMed ID: 28411578
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ producing T cells contribute to the increase of myeloid derived suppressor cells in tumor-bearing mice after cyclophosphamide treatment.
Guo Q; Lv Z; Fu Q; Jiang C; Liu Y; Lai L; Chen Q; Shen J; Wang Q
Int Immunopharmacol; 2012 Feb; 12(2):425-32. PubMed ID: 22226750
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer.
Liu D; You M; Xu Y; Li F; Zhang D; Li X; Hou Y
Int Immunopharmacol; 2016 Oct; 39():265-272. PubMed ID: 27497194
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
[TBL] [Abstract][Full Text] [Related]
7. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
Wu K; Tan MY; Jiang JT; Mu XY; Wang JR; Zhou WJ; Wang X; Li MQ; He YY; Liu ZH
Clin Immunol; 2018 Aug; 193():60-69. PubMed ID: 29410331
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Shariatpanahi SP; Shariatpanahi SP; Madjidzadeh K; Hassan M; Abedi-Valugerdi M
J Theor Biol; 2018 Apr; 442():1-10. PubMed ID: 29337259
[TBL] [Abstract][Full Text] [Related]
10. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
Zhou J; Donatelli SS; Gilvary DL; Tejera MM; Eksioglu EA; Chen X; Coppola D; Wei S; Djeu JY
Sci Rep; 2016 Jul; 6():29521. PubMed ID: 27405665
[TBL] [Abstract][Full Text] [Related]
12. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway.
Wang Y; Fan X; Wu X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32530032
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic chemotherapy in two mouse colon cancer models.
Taniura T; Iida Y; Kotani H; Ishitobi K; Tajima Y; Harada M
Cancer Sci; 2020 Oct; 111(10):3527-3539. PubMed ID: 32816355
[TBL] [Abstract][Full Text] [Related]
16. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
Lim HX; Choi S; Cho D; Kim TS
Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
[TBL] [Abstract][Full Text] [Related]
17. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
Fortin C; Yang Y; Huang X
Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
[TBL] [Abstract][Full Text] [Related]
18. Gansui-Banxia Decoction extraction inhibits MDSCs accumulation via AKT /STAT3/ERK signaling pathways to regulate antitumor immunity in C57bl/6 mice.
Feng XY; Chen BC; Li JC; Li JM; Li HM; Chen XQ; Liu D; Li RT
Phytomedicine; 2021 Dec; 93():153779. PubMed ID: 34638030
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.
Suk Lee Y; Davila E; Zhang T; Milmoe HP; Vogel SN; Bromberg JS; Scalea JR
Innate Immun; 2019 Jan; 25(1):46-59. PubMed ID: 30782043
[TBL] [Abstract][Full Text] [Related]
20. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.
Cao Y; Feng Y; Zhang Y; Zhu X; Jin F
BMC Cancer; 2016 Jun; 16():343. PubMed ID: 27246354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
